Original Publication Date: 1 May, 2015
Publication / Source: Pharmacogenomics
Authors: Shaheenah Dawood & Massimo Cristofanilli
Over the last two decades we have seen a number of important advances in the biological underpinnings of breast cancer that have had a significant impact either directly or indirectly on the management and ultimately on the prognostic outcome of this disease. First, we now know that breast cancer is a heterogeneous disease made up of a number of unique subtypes each with its own natural history and associated prognostic outcome .